ABSTRACT
No disponible
Subject(s)
Humans , Male , Adult , Dermatitis, Exfoliative/complications , Dermatitis, Exfoliative/diagnosis , Dermatitis, Exfoliative/drug therapy , Eosinophilia/complications , Eosinophilia/diagnosis , Drug Hypersensitivity/complications , Drug Hypersensitivity/diagnosis , Dermatitis, Exfoliative/physiopathology , Eosinophilia/physiopathology , Trimethoprim, Sulfamethoxazole Drug Combination/adverse effects , Edema/complications , Allopurinol/adverse effectsABSTRACT
PURPOSE: To define the long-term outcome of stent placement in iliac and femoropopliteal arteries. MATERIALS AND METHODS: Three hundred ten patients received 418 balloon-expandable Palmaz stents. Two hundred thirty stents were implanted in iliac arteries of 184 patients, and 188 stents were implanted in femoropopliteal arteries in 126 patients. Restenosis rates were based on results of angiography performed 4-6 months after stent placement. Long-term patency rates were determined with duplex ultrasound. RESULTS: Immediate procedural success was achieved in 309 patients. Acute thrombosis ( < 24 hours) occurred in five patients, and immediate clinical success in 288. The 30-day mortality and morbidity rates were 0% and 8%, respectively. Angiography performed at 6 months in 299 patients revealed restenosis rates of 0.5% in iliac lesions, 11% in superficial femoral artery (SFA) lesions, and 20% in popliteal lesions. Survival analysis revealed 4-year primary patency rates of 86% +/- 4.1 for iliac artery lesions, 65% +/- 7.5 for SFA lesions, and 50% +/- 17.7 for popliteal artery lesions. Most restenotic lesions were successfully treated with repeat angioplasty. CONCLUSION: Implantation of Palmaz stents in iliac arteries allows long-term primary patency to be maintained in most patients.
Subject(s)
Femoral Artery , Iliac Artery , Popliteal Artery , Stents , Aged , Arterial Occlusive Diseases/therapy , Female , Follow-Up Studies , Humans , Male , Middle Aged , Treatment Outcome , Vascular PatencyABSTRACT
The percutaneous common femoral arterial approach is usually used for endovascular management of lower limb arterial disease. This approach is sometimes impracticable because the femoral artery is the site of severe calcific atheromatous lesions which prevent arterial puncture or, when the superficial femoral lesions are ostial or proximal, make it impossible to position the introducer and advance the guide wire. The popliteal artery then becomes very useful for treating these lesions by a retrograde approach. Similarly, superficial femoral lesions which cannot be successfully dilated by the anterograde femoral approach may justify retrograde catheterisation via the popliteal artery. Between May 1988 and August 1991, the authors used the retrograde popliteal approach in 30 cases. They obtained 24 successes, 12 of which were associated with the implantation of an endoprosthesis. There was 1 complication at the puncture site a popliteal arteriovenous fistula was created but was treated successfully by surgery.
Subject(s)
Angioplasty/methods , Arterial Occlusive Diseases/surgery , Popliteal Artery , Adult , Aged , Aged, 80 and over , Blood Vessel Prosthesis , Female , Humans , Male , Middle AgedABSTRACT
Palmaz's stent is a fenestrated, expansible metallic stent with an apparently small tendency to thrombogenesis, so that anticoagulants are necessary only during the preintimalization period. This stent has recently been introduced in human pathology and has been used in this study for percutaneous or surgical correction of residual or recurrent post-angioplasty lesions. The development, theoretical indications and preliminary results obtained with the insertion of 25 Palmaz's stents into peripheral arteries are presented.
Subject(s)
Arterial Occlusive Diseases/surgery , Stents , Aged , Female , Femoral Artery/surgery , Follow-Up Studies , Humans , Iliac Artery/surgery , Male , Middle Aged , Popliteal Artery/surgeryABSTRACT
From May 1988 to November 1989, 79 of the 341 patients admitted to our center requiring angioplasty for peripheral artery disease were treated by laser angioplasty (LA) associated with secondary dilatation. Laser angioplasty was performed with and Nd-YAG laser coupled by an optical fiber to 1.8, 2.2 and 3 mm sapphires. The population studied included 64 men and 15 women (mean age: 66 years). Functional outcome before LA was class II in 85% of cases (n = 67) and class III and IV respectively in 10 (13%) and 2 patients. Laser angioplasty was the primary indication in 61 patients (77%) with a femoropopliteal (n = 53), iliac (n = 7) or axillary (n = 1) arterial obstruction. Laser angioplasty was the secondary indication in stenoses which could not be negotiated by a guide or balloon (23%; n = 18). Laser angioplasty led to repermeabilization of arterial occlusions in 82% of cases. The best results were obtained for short occlusions of less than 3 cm (n = 5; 100%) and for femoropopliteal lesions (n = 60; 85%). Stenoses were revascularized in all cases. Complementary dilatation was performed at the same time in all revascularized patients. Forty-seven revascularized patients were followed up 3 to 6 months after LA. Results were good in 36 cases (77%); restenosis occurred in 7 cases (15%); and reocclusion in 4 cases (8%). It was possible to treat all restenoses percutaneously (dilatation: n = 5; extruder: n = 1; stent: n = 1).(ABSTRACT TRUNCATED AT 250 WORDS)
Subject(s)
Angioplasty, Laser , Arterial Occlusive Diseases/surgery , Adult , Aged , Aged, 80 and over , Female , Follow-Up Studies , Humans , Male , Middle AgedABSTRACT
The term of Cockett's syndrome stands for a lower limb dysfunction with venous stasis originating from the left common iliac compression by the right common iliac artery at the pelvic inlet level. For the authors, there are three evolutive stages. -- first stage: a simple compression without any anatomic venous parietal lesion. -- second stage: to the previous, are added left common iliac vein lesions consisting of an inner vascular band formation. -- third stage: final evolution: ilio-femoral thrombosis. Therefore, the diagnosis must be done as early as possible. It lies on the left lower limb phlebography.
